These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10651846)

  • 1. Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease.
    Kaczur V; Takács M; Szalai C; Falus A; Nagy Z; Berencsi G; Balázs C
    Eur J Immunogenet; 2000 Feb; 27(1):17-23. PubMed ID: 10651846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymorphism of the 52 triplet gene (nucleotide 253) of the TSH receptor in Basedow-Graves patients and in healthy controls].
    Kaczur V; Szalai C; Falus A; Nagy Z; Krajczár G; Balázs C
    Orv Hetil; 1997 Jun; 138(25):1625-8. PubMed ID: 9265143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins.
    Ho SC; Goh SS; Khoo DH
    Thyroid; 2003 Jun; 13(6):523-8. PubMed ID: 12930595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants.
    Simanainen J; Kinch A; Westermark K; Winsa B; Bengtsson M; Schuppert F; Westermark B; Heldin NE
    Thyroid; 1999 Jan; 9(1):7-11. PubMed ID: 10037069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins.
    Bohr UR; Behr M; Loos U
    Biochim Biophys Acta; 1993 Dec; 1216(3):504-8. PubMed ID: 8268237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies of genetic susceptibility to Graves' disease in a Russian population.
    Chistiakov DA; Savost'anov KV; Turakulov RI; Petunina N; Balabolkin MI; Nosikov VV
    Med Sci Monit; 2002 Mar; 8(3):CR180-4. PubMed ID: 11887032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease.
    Watson PF; French A; Pickerill AP; McIntosh RS; Weetman AP
    J Clin Endocrinol Metab; 1995 Mar; 80(3):1032-5. PubMed ID: 7883818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No mutations in the translated region of exon 1 in the TSH receptor in Graves' thyroid glands.
    Ahmad MF; Stenszky V; Juhazs F; Balázs G; Farid NR
    Thyroid; 1994; 4(2):151-3. PubMed ID: 7919996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
    Kinjo Y; Takasu N; Komiya I; Tomoyose T; Takara M; Kouki T; Shimajiri Y; Yabiku K; Yoshimura H
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2593-6. PubMed ID: 12050220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between a thyrotropin receptor gene polymorphism and Graves' disease in the female population.
    Kotsa KD; Watson PF; Weetman AP
    Thyroid; 1997 Feb; 7(1):31-3. PubMed ID: 9086566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease.
    Chen RH; Chen WC; Chang CT; Tsai CH; Tsai FJ
    J Clin Lab Anal; 2005; 19(4):133-8. PubMed ID: 16025481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
    Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
    Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the relationship between TSHR gene and thyroid diseases.
    Shao L; Jiang H; Liang J; Niu X; Teng L; Zhang H
    Cell Biochem Biophys; 2011 Nov; 61(2):377-82. PubMed ID: 21830127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of polymorphic variants of IL-1β and IL-1RN genes in the development of Graves' disease in Kashmiri population (North India).
    Shehjar F; Afroze D; Misgar RA; Malik SA; Laway BA
    Hum Immunol; 2018 Apr; 79(4):228-232. PubMed ID: 29454070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.